An approach to enhance specificity against RNA targets using heteroconjugates of aminoglycosides and chloramphenicol (or linezolid).
D000081:Acetamides / Q000737:chemistry / Q000378:metabolism* / Q000494:pharmacology; D000617:Aminoglycosides / Q000138:chemical synthesis / Q000737:chemistry / Q000378:metabolism* / Q000494:pharmacology; D002701:Chloramphenicol / Q000737:chemistry / Q000378:metabolism* / Q000494:pharmacology; D005601:Framycetin / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D000069349:Linezolid; D009690:Nucleic Acid Conformation; D023303:Oxazolidinones / Q000737:chemistry / Q000378:metabolism* / Q000494:pharmacology; D012313:RNA / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000378:metabolism*; D013329:Structure-Activity Relationship; D013379:Substrate Specificity
D000081:Acetamides; D000617:Aminoglycosides; D023303:Oxazolidinones; D005601:Framycetin; D012313:RNA; D002701:Chloramphenicol; D000069349:Linezolid